ZYME

Zymeworks Inc.

Healthcare · Biotechnology

$253.35 sample

+4.15 (+1.67%) 1D

Market cap

$1.60T

Price as of

2026-10-03

Latest filing

8-K · 2026-09-24

Alerts

8

Price$253.35 +8.52% 3M daily closessample

255.84222.39

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 24SECForm 144 filed
Sep 21INSInsider sell: 10% owner
Sep 11INSInsider sell: Chief Executive Officer
Sep 02INSInsider sell: Chief Financial Officer
Aug 26INSInsider buy: Director
Aug 19INSInsider sell: General Counsel
Aug 10INSInsider sell: Chief Financial Officer
Aug 03INSInsider sell: Chief Executive Officer

Sign up to see the real ZYME record →

Company facts

SEC EDGAR registration

Name: Zymeworks Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +5sample, -100 to +100
Reporting currency: USD

Who is positioning in ZYME

sample

Insiders: 24 insider transactions over 90 days, net selling, $364.6M
Congress: 1 members traded over 90 days
Institutions · 13F: 38 funds hold $12.6B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$62.5B +14.8% y/y

Q4 2024Q3 2026

Inventory$35.8B +8.8% y/y

Q4 2024Q3 2026

Accounts receivable$27.8B +10.0% y/y

Q4 2024Q3 2026

Total debt$73.2B +9.5% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $1.13T -2.0% 3M
Sample peer B: $1.46T +1.5% 3M
Sample peer C: $537.3B -5.7% 3M
Sample peer D: $483.9B +2.8% 3M
Sample peer E: $939.6B +9.2% 3M